141 related articles for article (PubMed ID: 9002965)
21. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.
Gooding R; Riches P; Dadian G; Moore J; Gore M
Br J Cancer; 1995 Aug; 72(2):452-5. PubMed ID: 7640231
[TBL] [Abstract][Full Text] [Related]
22. Maturation of acute T-lymphoblastic leukemia cells after CD2 ligation and subsequent treatment with interleukin-2.
Mentz F; Ouaaz F; Michel A; Blanc C; Hervé P; Bismuth G; Debré P; Merle-Béral H; Mossalayi MD
Blood; 1994 Aug; 84(4):1182-92. PubMed ID: 7519476
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of the gamma c subunit of the IL-2, IL-4, and IL-7 receptors. Distinct interaction of gamma c in the IL-4 receptor.
He YW; Adkins B; Furse RK; Malek TR
J Immunol; 1995 Feb; 154(4):1596-605. PubMed ID: 7530740
[TBL] [Abstract][Full Text] [Related]
24. Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.
Lin WC; Yasumura S; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1229-35. PubMed ID: 8217083
[TBL] [Abstract][Full Text] [Related]
25. Cell type-specific tyrosine phosphorylation of IL-2 receptor beta chain in response to IL-2.
Kumaki S; Asao H; Takeshita T; Kurahayashi Y; Nakamura M; Beckers T; Engels JW; Sugamura K
FEBS Lett; 1992 Sep; 310(1):22-6. PubMed ID: 1526279
[TBL] [Abstract][Full Text] [Related]
26. Endocytosis of the beta chain of interleukin-2 receptor requires neither interleukin-2 nor the gamma chain.
Hémar A; Lieb M; Subtil A; DiSanto JP; Dautry-Varsat A
Eur J Immunol; 1994 Sep; 24(9):1951-5. PubMed ID: 8088315
[TBL] [Abstract][Full Text] [Related]
27. Expression of low-, intermediate-, and high-affinity IL-2 receptors on B cell lines derived from patients with undifferentiated lymphoma of Burkitt's and non-Burkitt's types.
Benjamin D; Rosolen A; Wormsley SB; DeBault LE; Colamonici OR
Cell Immunol; 1990 Aug; 129(1):112-24. PubMed ID: 2364438
[TBL] [Abstract][Full Text] [Related]
28. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
29. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.
Arima N; Kamio M; Imada K; Hori T; Hattori T; Tsudo M; Okuma M; Uchiyama T
J Exp Med; 1992 Nov; 176(5):1265-72. PubMed ID: 1402672
[TBL] [Abstract][Full Text] [Related]
30. Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells.
Nagarkatti M; Hassuneh M; Seth A; Manickasundari K; Nagarkatti PS
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7638-42. PubMed ID: 8052634
[TBL] [Abstract][Full Text] [Related]
31. Regulatory mechanisms for the expression of a functional beta chain of interleukin 2 receptor on T4 chronic lymphocytic leukemia cells.
Maeda Y; Hattori T; Sakai K; Yamamura Y; Murakami T; Asou N; Tsudo M; Takatsuki K
Growth Factors; 1991; 4(4):289-95. PubMed ID: 1764265
[TBL] [Abstract][Full Text] [Related]
32. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.
Kondo M; Takeshita T; Ishii N; Nakamura M; Watanabe S; Arai K; Sugamura K
Science; 1993 Dec; 262(5141):1874-7. PubMed ID: 8266076
[TBL] [Abstract][Full Text] [Related]
33. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Obiri NI; Puri RK
Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H
Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656
[TBL] [Abstract][Full Text] [Related]
35. Reconstitution of the intermediate-affinity interleukin-2 receptor by cell fusion.
Kuida K; Tanaka T; Kitamura F; Toyama-Sorimachi N; Miyasaka M
Int Immunol; 1992 Oct; 4(10):1123-8. PubMed ID: 1489730
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro.
Okamoto M; Hattori K; Oyasu R
Int J Cancer; 1997 Jul; 72(1):149-54. PubMed ID: 9212236
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
[TBL] [Abstract][Full Text] [Related]
38. The effects of blockade of interleukin 2 receptors and interleukin 4 receptors on cytokine production.
Lai KN; Leung JC; Li PK; Larche M; Ritter MA
APMIS; 1991 May; 99(5):434-42. PubMed ID: 1904250
[TBL] [Abstract][Full Text] [Related]
39. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism.
Kong B; Isozaki T; Sasaki S
Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.
Trentin L; Cerutti A; Zambello R; Sancretta R; Tassinari C; Facco M; Adami F; Rodeghiero F; Agostini C; Semenzato G
Blood; 1996 Apr; 87(8):3327-35. PubMed ID: 8605349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
